Partnership progresses from initial testing to commercial deployment, bringing MicroVision’s long-range lidar technology to LFT’s advanced airborne situational-awareness solutions ORLANDO, Fla. and MARKDORF, Germany – November 5, 2026 – MicroVision, Inc.
India – November 5, 2026 – A salaried employee can usually show a monthly salary slip and a predictable flow of income. For a freelancer, consultant, shop owner or entrepreneur, income
Robotics Market Mordor Intelligence has published a new report on the Robotics market, offering a comprehensive analysis of trends, growth drivers, and future projections. Hyderabad, India, November 05, 2026: Robotics
United Kingdom Home Insurance Market Size and Share | Mordor Intelligence Mordor Intelligence has published a new report on the UK Home Insurance Market offering a comprehensive analysis of trends,
Industrial Alcohol Market Size & Trends | Mordor Intelligence Mordor Intelligence has published a new report on the industrial alcohol market, offering a comprehensive analysis of market trends, growth drivers,
Mechanical Control Cables Market Mordor Intelligence has published a new report on the Mechanical Control Cables Market offering a comprehensive analysis of trends, growth drivers, and future projections. Hyderabad, India,
The Key Acute Coronary Syndrome Companies in the market include – AGEPHA Pharma, Amgen, Regeneron, Sanofi, Idorsia Pharmaceuticals, Viatris, Faraday Pharmaceuticals, Novo Nordisk, and others. (Albany, US), November 5, 2026
The Key Facioscapulohumeral Muscular Dystrophy Companies in the market include – Novartis (Avidity Biosciences), Arrowhead Pharmaceuticals, Scholar Rock, Epicrispr Biotechnologies, Restem, Modalis Therapeutics, and others. (Albany, US), November 05, 2026
The Key Dravet Syndrome Companies in the market include – Stoke Therapeutics, Biogen, Longboard Pharmaceuticals, Harmony Biosciences, Encoded Therapeutics, Jazz Pharmaceuticals, UCB, Zogenix, Biocodex, and others. (Albany, US), November 5,
The Key Complex Regional Pain Syndrome Companies in the market include – Abiogen Pharma, Ambros, and others. (Albany, US), November 5, 2026 – DelveInsight’s ‘Complex Regional Pain Syndrome (CRPS) –
(Albany, New York) – November 05, 2026: As per DelveInsight’s assessment, globally, Achondroplasia pipeline constitutes 10+ key companies continuously working towards developing 10+ Achondroplasia treatment therapies, analysis of Clinical Trials,
The Key Hemophilia A Companies in the market include – BioMarin Pharmaceutical, Ultragenyx Pharmaceutical, =CSL Behring, Novo Nordisk A/S, Bayer, Takeda, Sanofi, Biocad, Green Cross Corporation, Hoffmann-La Roche, Bayer, Spark
(Albany, New York) – November 05, 2026: As per DelveInsight’s assessment, globally, Fabry Disease pipeline constitutes 18+ key companies continuously working towards developing 18+ Fabry Disease treatment therapies, analysis of
The Key Non-Postoperative Pain Management Companies in the market include – Teikoku Pharma, Gensco Pharma, Scilex Holding Company, Cessatech A/S, Allodynic Therapeutics, Biohaven Therapeutics, Vaneltix Pharma, and others. (Albany, US),
Shenzhen, Guangdong, China – November 5, 2026 – Shenzhen Sunsred Technology Co., Ltd., an established manufacturer of medical-grade light therapy equipment, has announced the launch of its new Aura series
The Key Myelodysplastic Syndrome Companies in the market include – Geron, Servier, AbbVie, OrcaBio, Rigel Pharmaceuticals, University Hospital, Grenoble, Kind Pharmaceuticals LLC, Otsuka Beijing Research Institute, Agios Pharmaceuticals, Bristol-Myers Squibb,
(Albany, New York) – November 05, 2026: As per DelveInsight’s assessment, globally, Acute Lymphocytic Leukemia pipeline constitutes 120+ key companies continuously working towards developing 125+ Acute Lymphocytic Leukemia treatment therapies,
The market dynamics for Acid Sphingomyelinase Deficiency (ASMD) are expected to witness steady growth driven by increasing disease awareness, improved genetic testing and diagnosis rates, and the growing demand for
The market dynamics for Antiphospholipid Syndrome (APS) are expected to witness growth driven by the rising prevalence of autoimmune disorders, increasing awareness and diagnosis of APS, and the growing need
The market dynamics for Buerger’s disease are expected to evolve through 2036, driven by the high unmet medical need for effective treatment options, the growing focus on early diagnosis and
